NeoGenomics Inc (NEO): Shareholders' Equity
$836.56M
As of 2025-12-31
$785.73M
As of 2026-06-30
-5.7%
3-year compound annual growth
+3.8%
5-year compound annual growth
+14.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $836.56M | -7.3% | 2026-02-17, Balance as of period end |
| 2024-12-31 | $902.34M | -4.2% | 2026-02-17, Balance as of period end |
| 2023-12-31 | $941.54M | -5.7% | 2026-02-17, Balance as of period end |
| 2022-12-31 | $998.02M | -9.9% | 2025-02-18, Balance as of period end |
| 2021-12-31 | $1.11B | +59.6% | 2024-02-20, Balance as of period end |
| 2020-12-31 | $694.29M | +36.8% | 2023-02-24, Balance as of period end |
| 2019-12-31 | $507.41M | +58.3% | 2022-02-25, Balance as of period end |
| 2018-12-31 | $320.44M | +86.3% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $171.96M | +5.9% | 2020-02-28, Balance as of period end |
| 2016-12-31 | $162.32M | -22.5% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $209.51M | +246.8% | 2018-03-13, Balance as of period end |
| 2014-12-31 | $60.41M | +178.2% | 2017-03-14, Balance as of period end |
| 2013-12-31 | $21.71M | +135.6% | 2016-04-18, Balance as of period end |
| 2012-12-31 | $9.22M | +56.3% | 2015-03-03, Balance as of period end |
| 2011-12-31 | $5.90M | +88.1% | 2014-02-24, Balance as of period end |
| 2010-12-31 | $3.13M | n/a | 2012-03-12, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| NeoGenomics Inc (NEO) | 2025-12-31 | $836.56M | -7.3% |
| UL Solutions Inc. (ULS) | 2025-12-31 | $1.29B | +39.0% |
| 20/20 Biolabs, Inc. (AIDX) | 2025-12-31 | -$19.2K | n/m |
| Hypha Labs, Inc. (FUNI) | 2025-09-30 | -$2.44M | n/m |
Compare NEO, ULS, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗